INNOVEIN, INC
Prosthetic venous valve with minimally invasive delivery system for treating chronic venous insufficiency
- Sector
- Medtech
- Total capital
- $1.6M
- Federal grants
- $1.6M
- 2 awards · 2017–2019
- Rank in peer group#195 of 477
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 9 pending · first 2019
- Rank in peer group#99 of 477
Capital timeline
Latest events
- Federal grantNSF · Phase II · SBIR Phase II: Venous Valve Prosthesis as a Cure for Chronic Venous Insufficiency$1.4M
- Federal grantNSF · Phase I · SBIR Phase I: Venous Valve Prosthesis as a Cure for Chronic Venous Insufficiency$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grants#195 · top 41%
- Granted patents#99 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Albert K. ChinResearcherExecutive Officer, DirectorLinked by 3 patents
- Austin WalkerResearcherExecutive Officer, DirectorLinked by $1.6M in grants as PI
- David K. HovdaExecutive Officer, DirectorNamed in SEC Form D filings
- Robert WhirleyDirectorNamed in SEC Form D filings
- Thomas A. KramerExecutive OfficerNamed in SEC Form D filings
- Thomas Harold PierceExecutive Officer, PromoterNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 12- GrantedVenous Valve ProsthesisUSPTOUS 11,564,797
- PendingVenous Valve With Enhanced Flow PropertiesUSPTOApplication 17336429
- PendingVascular Valve ProsthesisUSPTOApplication 17142887
Show all 12 patent records
- Venous Valve ProsthesisJan 31, 2023 · US 11,564,797Granted
- Venous Valve With Enhanced Flow PropertiesDec 2, 2021 · Application 17336429Pending
- Vascular Valve ProsthesisJun 24, 2021 · Application 17142887Pending
- Vascular Valve ProsthesisFeb 9, 2021 · US 10,912,647Granted
- Venous Valve ProsthesisMar 19, 2019 · US 10,231,838Granted
- Venous Valve ProsthesisApplication PCTUS2016048729Pending
- Venous Valve ProsthesisApplication 62209351Pending
- Venous Valve ProsthesisApplication 62356337Pending
- Venous Valve With Enhanced Flow PropertiesApplication PCTUS2021035433Pending
- Venous Valve With Enhanced Flow PropertiesApplication 63033312Pending
- Vascular Valve ProsthesisApplication PCTUS2018037393Pending
- Venous Valve Prosthesis Device And MethodApplication 62518859Pending
Related companies, and why
- Innovein, Inc.Shares a founder: Austin Walker
- Cambrian Design and DevelopmentSimilar federal contract value in Medtech · null in contracts
- Zenwa IncSimilar federal contract value in Medtech · null in contracts
- Wearable Devices Ltd.Similar federal contract value in Medtech · null in contracts
- HEALTHCHART LLCSimilar federal contract value in Medtech · null in contracts
- ATLAS MEDTECH LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .